Dian Diagnostics Group Co. Ltd.

Dian Diagnostics Group Co. faced a notable decline in its stock price, contrasting with broader market trends. The company reported a significant drop in net sales and has experienced negative results for nine consecutive quarters, resulting in a negative return on equity. Its market capitalization is CNY 10,955 million.

Dian Diagnostics Group Co. faced a notable decline in stock performance, with significant drops over the past week and month. The company has reported negative financial results for nine consecutive quarters, including declines in net sales and profit, raising concerns about its profitability and market position.

Dian Diagnostics Group Co. faced notable stock declines on March 3, 2026, contrasting with the broader market's performance. Over the past month, the company has seen a significant downturn, with financial metrics indicating challenges, including a sharp drop in net profit and a negative return on capital employed.

Dian Diagnostics Group Co. faced notable stock activity on February 24, 2026, with a significant decline amid broader market trends. The company reported a sharp drop in net profit and low return on capital employed, highlighting operational challenges. Its long-term performance shows concerning declines over three and five years.